Simbiotika - Company finances
|
EUR
|
2023
From: 2023-05-05
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 31,736 | 72,336 | 116,686 |
| Profit before tax | 5,497 | 7,501 | 21,047 |
| Net profit | 5,497 | 7,126 | 19,784 |
| Equity | 5,697 | 12,818 | 32,602 |
| Liabilities | 823 | 0 | 8,596 |
| Non-current assets | 0 | 1,705 | 29,219 |
| Current assets | 6,520 | 15,163 | 11,979 |
| Total assets | 6,520 | 16,868 | 41,198 |
|
Taxes paid
|
|||
| STI taxes | 977 | 9,242 | 15,013 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +127.9% | +61.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 84.3% | 42.2% | 48.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 96.5% | 55.6% | 60.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 17.3% | 9.9% | 17.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 17.3% | 10.4% | 18.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | - | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Simbiotika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-03-03 | 2026-03-31 | 233.41 |
| 2026-02-03 | 2026-03-02 | 152.93 |
| 2025-12-02 | 2026-02-02 | 72.45 |
| 2025-09-02 | 2025-11-30 | 72.45 |
| 2025-06-03 | 2025-08-31 | 72.45 |
| 2025-05-04 | 2025-05-31 | 72.45 |
| 2025-03-01 | 2025-04-30 | 72.45 |
| 2025-02-01 | 2025-02-28 | 7.95 |
| 2024-05-02 | 2024-05-31 | 39.38 |
| 2024-04-03 | 2024-04-30 | 129.00 |
| 2024-03-01 | 2024-03-31 | 129.00 |
| 2024-02-06 | 2024-02-12 | 70.37 |
| 2024-02-01 | 2024-02-05 | 129.00 |
| 2023-12-07 | 2023-12-07 | 58.63 |
| 2023-12-01 | 2023-12-06 | 117.26 |
| 2023-11-03 | 2023-11-30 | 58.63 |
| 2023-10-03 | 2023-10-31 | 58.63 |
| 2023-07-03 | 2023-09-30 | 58.63 |
Simbiotika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-29 | 2026-02-16 | 0.1 |
| 2026-01-01 | 2026-01-24 | 0.1 |
| 2025-07-01 | 2025-12-29 | 0.1 |
| 2025-06-28 | 2025-06-28 | 0.8 |
| 2025-06-25 | 2025-06-25 | 375.8 |
| 2025-06-24 | 2025-06-24 | 375.7 |
| 2025-06-23 | 2025-06-23 | 375.6 |
| 2025-06-19 | 2025-06-22 | 375.0 |
| 2024-11-13 | 2024-11-18 | 9.68 |
| 2024-08-01 | 2024-11-12 | 0.68 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Simbiotika, MB (company code 306311573) is a Small partnership engaged in retail sale of cosmetic and toilet articles. In the latest financial year, 2025, the company generated revenue of €116.7K and net profit of €19.8K, with a profit margin of 16.9%. Performance improved strongly over the three-year period: revenue increased from €31.7K in 2023 to €72.3K in 2024 and then to €116.7K in 2025, while net profit rose from €5.5K to €7.1K and further to €19.8K. The balance sheet also strengthened in 2025, with total assets of €41.2K, equity of €32.6K and liabilities of €8.6K. Equity represented 79.1% of assets, and the debt-to-equity ratio was 0.26. Asset turnover reached 2.83x, indicating efficient use of assets in generating revenue. Return on equity was 60.7% and return on assets was 48.0%, both reflecting the strong profitability achieved in 2025.